PharmaZell and Novasep announce the creation of a leading CDMO and API manufacturer
PharmaZell, a leading supplier of highly resilient and specialty APIs, and Novasep, a major CDMO focused on complex small molecules and ADCs, announced today the closing of their merger, following exclusive negotiations initiated in September 2021.